These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6848183)

  • 21. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an in vitro and in vivo epithelial tumor model for the study of invasion.
    Pauli BU; Anderson SN; Memoli VA; Kuettner KE
    Cancer Res; 1980 Dec; 40(12):4571-80. PubMed ID: 7438091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression.
    Chen SC; Henry DO; Hicks DG; Reczek PR; Wong MK
    J Urol; 2009 Jan; 181(1):336-42. PubMed ID: 19010488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased agglutinability of bladder cells by concanavalin A after administration of carcinogens.
    Kakizoe T; Komatsu H; Niijima T; Kawachi T; Sugimura T
    Cancer Res; 1980 Jun; 40(6):2006-9. PubMed ID: 7371036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactosyl transferase activity in rat bladder transitional cell carcinoma lines and in exfoliated cells in urine during carcinogenesis and reversible hyperplasia.
    Plotkin GM; Gilbert SL; Wides RJ; Wolf G; Cohen SM; Fukushima S
    Cancer Biochem Biophys; 1980; 4(4):251-6. PubMed ID: 6778604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions.
    Rowland RG; Henneberry MO; Oyasu R; Grayhack JT
    Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo growth of human bladder cancer cell lines.
    Heaney JA; Ornellas EP; Daly JJ; Lin JC; Prout GR
    Invest Urol; 1978 Mar; 15(5):380-4. PubMed ID: 640800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
    Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
    J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model of bladder tumor xenografts in the nude rat.
    Oshinsky GS; Chen Y; Jarrett T; Anderson AE; Weiss GH
    J Urol; 1995 Nov; 154(5):1925-9. PubMed ID: 7563385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of urinary bladder carcinomas in male hamsters by N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide, N-(4-(5-nitro-2-furyl)-2-thiazolyl)-acetamide, or formic acid 2-(4-(5-nitro-2-furyl)-2-thiazolyl)hydrazide.
    Croft WA; Bryan GT
    J Natl Cancer Inst; 1973 Sep; 51(3):941-9. PubMed ID: 4743562
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1974 Mar; 11(5):392-5. PubMed ID: 4815625
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Murasaki G; Fukushima S; Greenfield RE
    Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
    [No Abstract]   [Full Text] [Related]  

  • 38. [A transurethrally transplanted model of a carcinoma in the area of the urinary bladder of the rabbit (author's transl)].
    Harzmann R; Gericke D; Bichler KH; Erdmann D
    Urologe A; 1978 Mar; 17(2):125-9. PubMed ID: 636118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.
    Furukawa T; Fu X; Kubota T; Watanabe M; Kitajima M; Hoffman RM
    Cancer Res; 1993 Mar; 53(5):1204-8. PubMed ID: 8439965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing syngeneic orthotopic murine bladder cancer (MB49).
    Günther JH; Jurczok A; Wulf T; Brandau S; Deinert I; Jocham D; Böhle A
    Cancer Res; 1999 Jun; 59(12):2834-7. PubMed ID: 10383142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.